ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,109Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 2680

$1.58M Total Retail Price of All Prescriptions

Rank: 11 out of 2680

873 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 873 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

4% of this provider’s 873 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 17,215 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
METOPROLOL TARTRATE 1,268 920 1 8
SIMVASTATIN 1,101 698 2 1
LEVOTHYROXINE SODIUM 985 627 3 4
WARFARIN SODIUM 879 678 4 12
LISINOPRIL 739 478 5 5
FUROSEMIDE 614 497 6 7
AMLODIPINE BESYLATE 561 396 7 3
MIRTAZAPINE 545 468 8 48
OMEPRAZOLE 518 282 9 2
CITALOPRAM HBR 467 387 10 22
POTASSIUM CHLORIDE 450 303 11 29
METFORMIN HCL 364 170 12 6
QUETIAPINE FUMARATE 336 246 13 72
RISPERIDONE 327 227 14 67
ALBUTEROL SULFATE 312 266 15 97
GABAPENTIN 290 99 16 21
TRAZODONE HCL 289 233 17 60
DONEPEZIL HCL 282 251 18 28
METOPROLOL SUCCINATE 267 163 19 11
HYDROCHLOROTHIAZIDE 257 135 20 9
BENZTROPINE MESYLATE 257 169 R 20 193
DIVALPROEX SODIUM 251 160 22 90
RANITIDINE HCL 251 186 22 35
SERTRALINE HCL 250 173 24 23
ATENOLOL 239 115 25 14
ENALAPRIL MALEATE 225 134 26 24
CLOPIDOGREL 219 150 27 30
HALOPERIDOL 214 163 28 153
IPRATROPIUM BROMIDE 208 180 29 157
CARVEDILOL 205 163 30 27
LACTULOSE 190 91 31 100
FAMOTIDINE 183 93 32 65
LANTUS 178 114 33 70
SPIRONOLACTONE 173 147 34 86
TAMSULOSIN HCL 166 112 35 25
OLANZAPINE 166 107 35 128
PANTOPRAZOLE SODIUM 164 69 37 44
PLAVIX 161 118 38 41
CLOZAPINE 160 44 39 226
DIGOXIN 159 124 40 59
LOSARTAN POTASSIUM 149 54 41 18
OXYCODONE-ACETAMINOPHEN 143 96 S2 42 106
LEVETIRACETAM 143 93 42 94
NOVOLOG 141 94 44 159
VENTOLIN HFA 140 60 45 61
IBUPROFEN 138 68 46 63
ATORVASTATIN CALCIUM 135 97 47 10
OXYBUTYNIN CHLORIDE 131 58 48 189
DIVALPROEX SODIUM ER 130 80 49 257
ALENDRONATE SODIUM 126 86 50 20
SEROQUEL 125 103 51 161
ABILIFY 123 76 52 192
CARBIDOPA-LEVODOPA 122 101 53 88
LOVASTATIN 115 82 54 37
PHENYTOIN SODIUM EXTENDED 113 87 55 207
GLIPIZIDE 111 75 56 71
ISOSORBIDE MONONITRATE ER 110 78 57 57
NAMENDA 110 109 57 43
VALPROIC ACID 109 75 59 221
SANTYL 108 88 60 144
PREDNISONE 105 81 61 45
SINGULAIR 104 45 62 64
PRAVASTATIN SODIUM 101 62 63 16
NYSTATIN-TRIAMCINOLONE 100 81 64 140
ADVAIR DISKUS 99 74 65 32
CRESTOR 96 60 66 15
CYMBALTA 95 75 67 56
PAROXETINE HCL 92 69 68 62
OXYCODONE HCL 90 63 S2 69 93
NIFEDIPINE ER 89 44 70 73
CLONIDINE HCL 88 55 71 84
SPIRIVA 83 71 72 36
CIPROFLOXACIN HCL 81 62 73 85
CEPHALEXIN 80 55 74 132
NYSTATIN 80 56 74 160
GEMFIBROZIL 78 44 76 119
TRAVATAN Z 78 66 76 234
BACLOFEN 78 36 76 123
RAMIPRIL 77 53 79 49
ESCITALOPRAM OXALATE 75 61 80 82
POLYETHYLENE GLYCOL 3350 75 44 80 55
LEVEMIR 72 20 82 224
MUPIROCIN 71 57 83 152
HYDROCODONE-ACETAMINOPHEN 71 39 S3 83 13
GLIPIZIDE ER 71 32 83 116
ZOLPIDEM TARTRATE 70 49 86 17
DILTIAZEM 24HR CD 70 47 86 148
SILVER SULFADIAZINE 68 54 88 227
TORSEMIDE 68 36 88 169
ALLOPURINOL 67 52 90 42
CHLORHEXIDINE GLUCONATE 67 22 90 166
FINASTERIDE 64 50 92 80
SSD 63 53 93 286
HYDRALAZINE HCL 61 53 94 99
DIOVAN 60 43 95 26
INSULIN SYRINGE 60 19 95 187
KLOR-CON M20 57 54 97 101
LATANOPROST 57 57 97 195
AMOX TR-POTASSIUM CLAVULANATE 57 44 97 145
MONTELUKAST SODIUM 56 19 100 134
KETOCONAZOLE 56 45 100 244
CARBAMAZEPINE 56 29 100 184
GLIMEPIRIDE 55 16 103 51
NEXIUM 55 0 103 19
THEOPHYLLINE ANHYDROUS 53 29 105 336
VENLAFAXINE HCL 51 22 106 305
TRAMADOL HCL 51 20 106 33
NIASPAN 51 36 106 120
FENTANYL 51 33 S2 106 102
LIPITOR 51 26 106 78
CLOTRIMAZOLE-BETAMETHASONE 50 28 111 109
LOSARTAN-HYDROCHLOROTHIAZIDE 50 47 111 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 30, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.